OctoPlus N.V.

Company description

OctoPlus is a specialty pharmaceutical company and internationally established as a provider of pharmaceutical development services, drug delivery technology and cGMP manufacturing to biotech and pharma companies worldwide. We develop high-end formulation solutions for our clients in order to help them bring innovative pharmaceutical products from lab bench to the clinic and onto the market. We are one of the leading specialised contract pharmaceutical development companies in the world. We have extensive formulation expertise on all types of active ingredients (small molecules, proteins, peptides, RNA, DNA) and specialise in injectables. We also offer proprietary drug delivery technologies for the development of improved pharmaceutical products with less side effects, increased patient compliance and better efficacy. We do this for our clients based on either marketed or new pharmaceutical ingredients.

Interviews

Interview with Jan Egberts, CEO, OctoPlus N.V.

Clearly the end of 2010 was an exciting time for you. As you entered the transition period as the new CEO of OctoPlus, you also participated in the equity raising.…

Interview with Harry Flore, CEO, HAL Allergy Group

Our meetings frequently bring us here to the Leiden Bio Science Park, but more often than not, to meet with younger, up-and-coming companies. HAL Allergy, meanwhile, has a rich and…

Interview with Bernie Tobin, General Manager, Amgen B.V.

You are still relatively new to the Netherlands having been here for one year. This must be a very insightful experience abroad. What were your initial expectations and first impressions…

Interview with Andrew Oxtoby, Managing Director, Lilly Nederland BV

You began as managing director of this Dutch affiliate close to one year ago. What was the trajectory that led you to this position and what were your initial impressions…

Interview with Onno van de Stolpe, Chief Executive Officer, Galapagos NV

Since its founding Galapagos has operated with a hybrid business model which has combined its internal discoveries with service activities. This model has worked quite well as it has now…

Interview with Niels Hessmann, Managing Director, Bayer BV Netherlands

As much as this report is about business trends and insights, we also like to portray the personalities of the industry in the markets that we cover. What has been…

Interview with Paul Flapper, General Manager, Shire International Licensing BV…

Shire has many offices in America, Europe, as well as in Singapore, in Japan and in Australia. The group has a vast global network and a strong presence in these…

Interview with Han Willems, General Manager, Promega Netherlands

Promega is a truly global company with a vast international presence. What would you say is the strategic importance that the Benelux affiliate has assumed within Promega’s global network? Promega…

Page: 8 | 1 2 3 4 5 6 7 8 article {"post_type":["article","interviews"],"posts_per_page":12,"tax_query":[{"taxonomy":"countries","field":"term_id","terms":127,"include_children":true}],"orderby":"date","order":"desc","max_num_pages":3,"paged":8,"post__not_in":[]}